BMJ Open · Nov 12, 2026

Prehabilitation before cytoreductive or debulking surgery for peritoneal malignancies: a scoping review

By Sand O, Graf W, Cashin P et al.

Objectives To map the extent, characteristics and findings of research on prehabilitation interventions including at least one component of physical exercise for patients undergoing surgery for peritoneal malignancies and to identify research gaps. Design We conducted a scoping review following Joanna Briggs Institute methodology. Data sources Six databases were systematically searched from inception to November 2025. Reference lists of the included articles were also screened. Eligibility Quantitative, qualitative and mixed-methods studies published in English or Swedish were eligible if they included adults undergoing cytoreductive surgery (CRS) or debulking surgery with/without hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancies and evaluated prehabilitation interventions comprising at least one component of physical exercise. Screening and data extraction Sources were screened in Rayyan and data were extracted using a Microsoft Excel spreadsheet. Data were synthesised descriptively. Results 15 articles from 14 studies published between 2021 and 2025 were included. Most studies were conducted in Europe and predominantly involved ovarian cancer patients. Studies were mainly small, non-randomised and feasibility-focused. Most combined resistance training and aerobic exercise within multimodal interventions. Prehabilitation was commonly described as feasible and acceptable, and within-group improvements in functional-capacity measures were commonly reported, although evidence from between-group comparisons was limited. Findings related to postoperative, nutritional and psychological outcomes and setting were heterogeneous. Conclusions The current body of research on prehabilitation in patients undergoing CRS or debulking surgery with/without HIPEC is recent, limited and heterogeneous in study design, intervention content and outcome measures. Furthermore, it is heavily dominated by ovarian cancer, limiting generalisability of findings to males and patients with non-gynaecological peritoneal malignancies. Future research should prioritise adequately powered randomised controlled trials, transparent reporting of intervention components and controls, and carefully select outcome measures to enable accurate evaluation of prehabilitation in this population. Trial registration number An a priori protocol was registered in Open Science Framework (DOI: 10.17605/OSF.IO/R2BH8).

doi.org/10.1136/bmjopen-2026-122515Open accessInterventions

AgingResearch.News